Muutke küpsiste eelistusi

E-raamat: Kidney in Plasma Cell Dyscrasias

Edited by , Series edited by
  • Formaat - PDF+DRM
  • Hind: 251,16 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

In recent years, the knowledge of how renal damage occurs in patients with plasma cell dyscrasias / myeloma has substantially increased. For the first time, this publication brings together issues relating to the diagnosis and pathogenesis of these disorders, as well as a summary of advances achieved in the treatment and management of patients. Several chapters are devoted to various glomerulopathies associated with deposition of immunoglobulin light and heavy chains, including those associated with amyloidosis. The sequential events are pointed out, crucial steps and key molecules open to modulation or control are delineated, and therapeutic advances are highlighted. Although the emphasis is on the management of cases with renal involvement, a distinct focus on the diseases as a whole and their impact on patients general health and prognosis has been maintained throughout the discussions. Using a translational approach to renal manifestations in patients with plasma cell dyscrasias / myelomas, this publication conveys a comprehensive state-of-the-art view of the subject. It is aimed at practicing renal pathologists, nephrologists, internists and hematologists, as well as at trainees and scientists working in these specialties.
Introduction
The Kidney in Plasma Cell Dyscrasias: A Current View and a Look at the Future
1(4)
Herrear, G.A. (Saint Louis, Mo.)
A History of the Kidney in Plasma Cell Disorders
5(20)
Steensma, D.P.; Kyle, R.A. (Rochester, Minn.)
Pathologic Studies Useful for the Diagnosis and Monitoring of Plasma Cell Dyscrasias
25(19)
Veillon, D.M.; Cotelingam, J.D. (Shreveport, La.)
Serum Free Light Chains in the Diagnosis and Monitoring of Patients with Plasma Cell Dyscrasias
44(22)
Mayo, M.M.; Schaef Johns, G. (St. Louis, Mo.)
Mechanisms of Renal Damage in Plasma Cell Dyscrasias: An Overview
66(21)
Merlini, G. (Pavia); Pozzi, C. (Lecco)
Proximal Tubular Injury in Myeloma
87(18)
Batuman, V. (New Orleans, La.)
Paraproteinemic Renal Diseases that Involve the Tubulo-Interstitium
105(11)
Herrera, G.A. (St. Louis, Mo.); Sanders, P.W. (Birmingham, Ala.)
The Mesangium as a Target for Glomerulopathic Light and Heavy Chains: Pathogenic Considerations in Light and Heavy Chain-Mediated Glomerular Damage
116(19)
Keeling, J.; Herrera, G.A. (St. Louis, Mo.)
Immunoglobulin Light and Heavy Chain Amyloidosis AL/AH: Renal Pathology and Differential Diagnosis
135(21)
Picken, M.M. (Maywood, III.)
Diversity and Diversification of Light Chains in Myeloma: The Specter of Amyloidogenesis by Proxy
156(26)
Gu, M.; Wilton, R.; Stevens, F.J. (Argonne, III.)
High-Dose Therapy in Patients with Plasma Cell Dyscrasias and Renal Dysfunction
182(13)
Pineda-Roman, M.; Tricot, G. (Little Rock, Ark.)
Current and Emerging Views and Treatments of Systemic Immunoglobulin Light-Chain (AL) Amyloidosis
195(16)
Comenzo, R.L. (New York, N.Y.)
Author Index 211(1)
Subject Index 212